Manuel R. Cabrera

491 total citations
10 papers, 379 citations indexed

About

Manuel R. Cabrera is a scholar working on Geriatrics and Gerontology, General Health Professions and Pharmacology. According to data from OpenAlex, Manuel R. Cabrera has authored 10 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Geriatrics and Gerontology, 2 papers in General Health Professions and 2 papers in Pharmacology. Recurrent topics in Manuel R. Cabrera's work include Pharmaceutical Practices and Patient Outcomes (3 papers), Asthma and respiratory diseases (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). Manuel R. Cabrera is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (3 papers), Asthma and respiratory diseases (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). Manuel R. Cabrera collaborates with scholars based in United States. Manuel R. Cabrera's co-authors include George Hripcsak, Joseph Finkelstein, Carol Friedman, J. Finkelstein, Randolph P. Cole, Vesselin Z. Miloushev and Masanori Ichise and has published in prestigious journals such as CHEST Journal, Journal of Asthma and Clinical Nuclear Medicine.

In The Last Decade

Manuel R. Cabrera

10 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Manuel R. Cabrera United States	8	122	86	79	57	42	10	379
Leili Lind Sweden	13	95 0.8×	59 0.7×	26 0.3×	105 1.8×	6 0.1×	33	423
Janice L. Clarke United States	14	177 1.5×	27 0.3×	17 0.2×	78 1.4×	7 0.2×	37	507
Valentin Boudo Burkina Faso	10	108 0.9×	24 0.3×	37 0.5×	29 0.5×	5 0.1×	27	394
Abdulaziz Alhossan Saudi Arabia	14	73 0.6×	200 2.3×	252 3.2×	59 1.0×	19 0.5×	58	801
Eunme Cha United States	10	74 0.6×	168 2.0×	61 0.8×	64 1.1×	5 0.1×	15	425
Jonathan Willner United States	13	220 1.8×	67 0.8×	81 1.0×	67 1.2×	8 0.2×	33	872
Timothy M. Herr United States	6	53 0.4×	70 0.8×	53 0.7×	66 1.2×	28 0.7×	10	506
Francisco Jódar‐Sánchez Spain	10	107 0.9×	48 0.6×	34 0.4×	58 1.0×	4 0.1×	28	361
Jaana Isojärvi Finland	9	38 0.3×	44 0.5×	61 0.8×	44 0.8×	7 0.2×	20	394
Claire Tobin Australia	11	64 0.5×	324 3.8×	16 0.2×	171 3.0×	22 0.5×	15	699

Countries citing papers authored by Manuel R. Cabrera

Since Specialization

Citations

This map shows the geographic impact of Manuel R. Cabrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel R. Cabrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel R. Cabrera more than expected).

Fields of papers citing papers by Manuel R. Cabrera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel R. Cabrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel R. Cabrera. The network helps show where Manuel R. Cabrera may publish in the future.

Co-authorship network of co-authors of Manuel R. Cabrera

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel R. Cabrera. A scholar is included among the top collaborators of Manuel R. Cabrera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel R. Cabrera. Manuel R. Cabrera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Finkelstein, Joseph, Carol Friedman, George Hripcsak, & Manuel R. Cabrera. (2016). Potential utility of precision medicine for older adults with polypharmacy: a case series study. Pharmacogenomics and Personalized Medicine. 9. 31–31. 37 indexed citations

2.

Finkelstein, Joseph, Carol Friedman, George Hripcsak, & Manuel R. Cabrera. (2016). Pharmacogenetic polymorphism as an independent risk factor for frequent hospitalizations in older adults with polypharmacy: a pilot study. Pharmacogenomics and Personalized Medicine. Volume 9. 107–116. 30 indexed citations

3.

Cabrera, Manuel R. & Joseph Finkelstein. (2016). A Use Case to Support Precision Medicine for Frequently Hospitalized Older Adults with Polypharmacy.. PubMed. 2016. 16–21. 6 indexed citations

4.

Miloushev, Vesselin Z., Manuel R. Cabrera, & Masanori Ichise. (2014). A Case of Immunogammaglobulin 4–Related Disease. Clinical Nuclear Medicine. 39(6). 537–539. 7 indexed citations

5.

Finkelstein, J., Manuel R. Cabrera, & George Hripcsak. (2002). Web-based monitoring of asthma severity: a new approach to ambulatory management. 139–143. 14 indexed citations

6.

Finkelstein, Joseph, Manuel R. Cabrera, & George Hripcsak. (2000). Internet-Based Home Asthma Telemonitoring. CHEST Journal. 117(1). 148–155. 175 indexed citations

7.

Finkelstein, Joseph, George Hripcsak, & Manuel R. Cabrera. (1998). Telematic system for monitoring of asthma severity in patients' homes.. PubMed. 52 Pt 1. 272–6. 52 indexed citations

8.

Finkelstein, Joseph, George Hripcsak, & Manuel R. Cabrera. (1998). Patients' acceptance of Internet-based home asthma telemonitoring.. PubMed. 336–40. 33 indexed citations

9.

Cabrera, Manuel R., et al.. (1995). No Association Found BetweenStrongyloidesInfestation and Asthma. Journal of Asthma. 32(1). 57–62. 9 indexed citations

10.

Cabrera, Manuel R., et al.. (1989). Effect of Airway Pressure on Pericardial Pressure. American Review of Respiratory Disease. 140(3). 659–667. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact